Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
Trusted Information Creator
Certified November 2025
{arrow_up} Back to top

Denbrayce 120 mg Solution for injection {equilateral_black_triangle}

Active Ingredient:
denosumab
Company:  
Mabxience Research S.L See contact details
ATC code: 
M05BX04
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Denbrayce 120 mg - Patient reminder card

This reminder card contains important safety information that the patient needs to be aware of before and during treatment with denosumab 120 mg injections for cancer-related conditions or giant cell tumour of bone (GCTB).

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Mabxience Research S.L
Company image
Address
Telephone
+ 34 917 71 15 00
Medical Information Direct Line
+34 675 531 773
Medical Information e-mail
[email protected]
WWW
www.mabxience.com